Synthomer (LON:SYNT) Shares Cross Above 200-Day Moving Average of $187.34

Synthomer plc (LON:SYNTGet Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 187.34 ($2.35) and traded as high as GBX 264.50 ($3.32). Synthomer shares last traded at GBX 260 ($3.27), with a volume of 246,465 shares changing hands.

Analyst Ratings Changes

Separately, Berenberg Bank restated a “buy” rating and set a GBX 320 ($4.02) price objective on shares of Synthomer in a report on Wednesday, March 13th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of GBX 224.40 ($2.82).

Get Our Latest Report on SYNT

Synthomer Price Performance

The company has a market cap of £440.00 million, a price-to-earnings ratio of -216.67, a PEG ratio of -0.17 and a beta of 1.78. The company has a quick ratio of 0.97, a current ratio of 1.95 and a debt-to-equity ratio of 79.72. The company’s fifty day moving average price is GBX 217.05 and its two-hundred day moving average price is GBX 187.34.

About Synthomer

(Get Free Report)

Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.

See Also

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.